» Articles » PMID: 27535144

Hospitalization for Influenza A Versus B

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2016 Aug 19
PMID 27535144
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The extent to which influenza A and B infection differs remains uncertain.

Methods: Using active surveillance data from the Canadian Immunization Monitoring Program Active at 12 pediatric hospitals, we compared clinical characteristics and outcomes of children ≤16 years admitted with laboratory-confirmed influenza B or seasonal influenza A. We also examined factors associated with ICU admission in children hospitalized with influenza B.

Results: Over 8 nonpandemic influenza seasons (2004-2013), we identified 1510 influenza B and 2645 influenza A cases; median ages were 3.9 and 2.0 years, respectively (P < .0001). Compared with influenza A patients, influenza B patients were more likely to have a vaccine-indicated condition (odds ratio [OR] = 1.30; 95% confidence interval [CI] = 1.14-1.47). Symptoms more often associated with influenza B were headache, abdominal pain, and myalgia (P < .0001 for all symptoms after adjustment for age and health status). The proportion of deaths attributable to influenza was significantly greater for influenza B (1.1%) than influenza A (0.4%); adjusted for age and health status, OR was 2.65 (95% CI = 1.18-5.94). A similar adjusted OR was obtained for all-cause mortality (OR = 2.95; 95% CI = 1.34-6.49). Among healthy children with influenza B, age ≥10 years (relative to <6 months) was associated with the greatest odds of ICU admission (OR = 5.79; 95% CI = 1.91-17.57).

Conclusions: Mortality associated with pediatric influenza B infection was greater than that of influenza A. Among healthy children hosptialized with influenza B, those 10 years and older had a significant risk of ICU admission.

Citing Articles

Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention.

Presa J, Arranz-Herrero J, Alvarez-Losa L, Rius-Rocabert S, Pozuelo M, Lalueza A Eur Respir Rev. 2025; 34(175).

PMID: 39778922 PMC: 11707602. DOI: 10.1183/16000617.0144-2024.


National Influenza Annual Report 2023-2024: A focus on influenza B and public health implications.

Ben Moussa M, Nwosu A, Schmidt K, Buckrell S, Rahal A, Lee L Can Commun Dis Rep. 2024; 50(11):393-399.

PMID: 39525075 PMC: 11542548. DOI: 10.14745/ccdr.v50i11a03.


A comprehensive review of influenza B virus, its biological and clinical aspects.

Ashraf M, Asif Raza M, Amjad M, Din G, Yue L, Shen B Front Microbiol. 2024; 15:1467029.

PMID: 39296301 PMC: 11408344. DOI: 10.3389/fmicb.2024.1467029.


Comparison of Clinical Presentations and Disease Severity of Children Hospitalized with Influenza A and B.

Eksi A, Kartal Ozturk G, Cicek C, Gulen F, Demir E Turk Arch Pediatr. 2024; 59(4):397-403.

PMID: 39140694 PMC: 11332444. DOI: 10.5152/TurkArchPediatr.2024.23286.


Determinants of influenza non-vaccination among Canadian children: insights from a nationwide survey.

Alami A, Dave S, Uhlik C, Ebrahim M, Krewski D, Laroche J Front Public Health. 2024; 12:1400782.

PMID: 38903582 PMC: 11188407. DOI: 10.3389/fpubh.2024.1400782.